Author:
Bhadwal Priyanka,Agnihotri Navneet
Publisher
Springer Nature Singapore
Reference152 articles.
1. Abadi A, Yavari P, Dehghani-Arani M, Alavi-Majd H, Ghasemi E, Amanpour F et al (2014) Cox models survival analysis based on breast cancer treatments. Iran J Cancer Prev 7:124–129
2. Abnet CC, Borkowf CB, Qiao Y-L, Albert PS, Wang E, Merrill AH Jr et al (2001) A cross-sectional study of human serum sphingolipids, diet and physiologic parameters. J Nutr 131:2748–2752
3. Alberg AJ, Armeson K, Pierce JS, Bielawski J, Bielawska A, Visvanathan K et al (2013) Plasma sphingolipids and lung cancer: a population-based, nested case–control study. Cancer Epidemiol Biomark Prev 22:1374–1382
4. Aoyama Y, Sobue S, Mizutani N, Inoue C, Kawamoto Y, Nishizawa Y et al (2017) Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR. Biochem Biophys Res Commun 486:551–557
5. Baghestani AR, Moghaddam SS, Majd HA, Akbari ME, Nafissi N, Gohari K (2015) Survival analysis of patients with breast cancer using Weibull parametric model. Asian Pac J Cancer Prev 16:8567–8571